| Drug Name: | Abciximab (143653-53-6) |
|---|---|
| PubChem ID: | |
| SMILES: | |
| InchiKey: | |
| Therapeutic Category: | Anticoagulants, Hematologic Agents, Platelet Aggregation Inhibitors |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Enoxaparin (9005-49-6) | Bleeding | Additive | Not clear | Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Antiplatelet Effect | Integrin Alpha-IIb precursor (P08514) | Antiplatelet effect [ ADR Type 1 ] | Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. |
| Antiplatelet Effect | Integrin beta-3 precursor (P05106) | Antiplatelet effect [ ADR Type 1 ] | Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category